Inventor · disambiguated record
John Spencer Emtage
Also filed as: EMTAGE JOHN S · EMTAGE JOHN SPENCER
20 granted patents·6 pending applications·7,314 citations·filing 1980–2021
97Inventor score
Top patents by PatentIndex Score
26 records- 0199US6632927B2Humanized antibodiesCELLTECH THERAPEUTICS LTD·Filed 2001·Granted Oct 14, 2003·809 cites·7 claims
- 0299US5859205AHumanised antibodiesCELLTECH LTD·Filed 1994·Granted Jan 12, 1999·2.3k cites·8 claims
- 0398US4816397AMultichain polypeptides or proteins and processes for their productionCELLTECH LTD·Filed 1984·Granted Mar 28, 1989·3.1k cites·18 claims
- 0497US7262050B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Aug 28, 2007·53 cites·7 claims
- 0597US5994510ARecombinant antibodies specific for TNFαCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Nov 30, 1999·233 cites·3 claims
- 0696US6180377B1Humanized antibodiesCELLTECH THERAPEUTICS LTD·Filed 1993·Granted Jan 30, 2001·473 cites·17 claims
- 0795US7244615B2Humanized antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 17, 2007·30 cites·7 claims
- 0895US7241877B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 10, 2007·32 cites·7 claims
- 0994US7244832B2Humanised antibodiesCELLTECH R&D LTD·Filed 2003·Granted Jul 17, 2007·32 cites·7 claims
- 1092US7566771B1Humanised antibodiesCELLTECH R&D LTD·Filed 1995·Granted Jul 28, 2009·73 cites·19 claims
- 1188USRE48787EHumanised antibodiesUCB Biopharma SRL·Filed 2019·Granted Oct 26, 2021·2 cites·19 claims
- 1282USRE50178EHumanised antibodiesUCB Biopharma SRL·Filed 2021·Granted Oct 22, 2024·0 cites·20 claims
- 1379US6734286B2Interleukin-5 specific recombinant antibodiesCELLTECH R&D LTD·Filed 2001·Granted May 11, 2004·9 cites·7 claims
- 1479US4357421ASynthetic gene coding for influenza hemagglutininSEARLE & CO·Filed 1980·Granted Nov 2, 1982·21 cites·20 claims
- 1578USRE39548EInterleukin-5 specific recombinant antibodiesCELLTECH R&D LTD·Filed 2001·Granted Apr 3, 2007·4 cites·7 claims
- 1673US4349629APlasmid vectors, production anduse thereofSEARLE & CO·Filed 1980·Granted Sep 14, 1982·35 cites·14 claims
- 1770US2005136054A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 1870US2005123534A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 1970US2006029593A1Humanised antibodiesCELLTECH R&D LTD·Filed 2004·Application pending·0 cites
- 2065US5998586AInterleukin-5 specific recombinant antibodiesCELLTECH THERAPEUTICS LTD·Filed 1995·Granted Dec 7, 1999·17 cites·4 claims
- 2164US2006073136A1Humanised antibodiesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
- 2264US2006073137A1Humanised antibodiesCELLTECH R&D LTD·Filed 2005·Application pending·0 cites
- 2356US6316227B1Nucleic acids encoding interleukin-5 specific recombinant antibodiesCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Nov 13, 2001·9 cites·8 claims
- 2451US6013642AUse of estrone derivatives as steroid sulphatase inhibitorsFiled 1995·Granted Jan 11, 2000·19 cites·5 claims
- 2544US2003199679A1Recombinant antibodies specific for TNF-alphaFiled 2003·Application pending·0 cites
- 2627US5747290AProcess for the production of recombinant polypeptidesSOUTHERN CROSS BIOTECH PARTY L·Filed 1995·Granted May 5, 1998·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when John Spencer Emtage files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →